Engitix Therapeutics
PrivateLast Round
Series A
Extension
Jan 8, 2026
Total Funding Raised
$86M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Engitix Therapeutics is a biotechnology company that develops therapies for cancer and fibrosis by targeting the extracellular matrix (ECM).
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Engitix Therapeutics Comparables
Compare Engitix Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Apmonia Therapeutics | 76% | |
| Aspect Biosystems | 66% | |
| leadXpro AG | 64% | |
Engitix Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jan 8, 2026 | ||||
| Series A | Jan 19, 2022 | ||||
| Seed | Nov 27, 2018 |
Key People
Founding team and executive leadership
Engitix Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Netherton Investments | Seed, Series A, Series A Extension |
| UCL Business | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 8, 2026
Raised $25M in Series A Extension funding.
- Nov 27, 2018
$7M round led by Netherton Investments
Engitix Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Engitix Therapeutics's valuation, stock price, and market status.